A Unique Model for Treating Chronic Hepatitis C in Patients With Psychiatric Disorders, Substance Abuse, and/or Housing Instability

被引:16
|
作者
Ho, Cheryl J. [1 ,3 ]
Preston, Charles [1 ]
Fredericks, Kim [1 ]
Doorley, Sara L. [1 ,3 ]
Kramer, Richard J. [2 ,3 ]
Kwan, Lawrence [1 ]
Kamal, Ahmad [2 ,3 ]
机构
[1] Santa Clara Valley Med Ctr, Dept Med, Div Primary Care, Valley Homeless Healthcare Program, San Jose, CA 95128 USA
[2] Santa Clara Valley Med Ctr, Div Gastroenterol, San Jose, CA 95128 USA
[3] Stanford Univ, Sch Med, Stanford, CA 94305 USA
关键词
Hepatitis C; homeless persons; injection drug use; interdisciplinary communication; mental illness; patient-centered care; METHADONE-MAINTENANCE TREATMENT; VIRUS-INFECTED PATIENTS; ILLICIT-DRUG-USERS; INTERFERON-ALPHA; RANDOMIZED-TRIAL; PLUS RIBAVIRIN; UNITED-STATES; OUTCOMES; PROGRAM; CARE;
D O I
10.1097/ADM.0b013e31829b1a6c
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Individuals with psychiatric disease, substance abuse, and/or housing instability have a high prevalence of chronic hepatitis C virus (HCV) infection. However, such individuals are often excluded from treatment for HCV infection because of a perceived inability to adhere to the rigorous medication regimen required. Methods: A pilot program using a multidisciplinary group medical visit model to treat HCV infection in the aforementioned population was created. Medication adherence and virologic response rates were prospectively followed. Results: Approximately 80% of patients were adherent to their HCV infection treatment regimen, as measured by attendance at group medical visits and by medication adherence. A sustained virologic response rate of 55% among individuals with genotype 1 infection and 80% among individuals with genotype 2 or 3 infections was observed. These results compare favorably with those seen in large, randomized controlled trials. Rates of discontinuation and adverse effects were similar to those seen in other studies. Conclusions: An intensive, multidisciplinary treatment approach toward HCV infection treatment can achieve favorable results even in persons traditionally considered to be "poor treatment candidates." Programs aimed at bringing HCV infection treatment to this population are needed.
引用
收藏
页码:320 / 324
页数:5
相关论文
共 50 条
  • [41] Older adult patients with both psychiatric and substance abuse disorders: Prevalence and health service use
    Prigerson, HG
    Desai, RA
    Rosenheck, RA
    PSYCHIATRIC QUARTERLY, 2001, 72 (01) : 1 - 18
  • [42] Screening for substance abuse and psychiatric disorders among women patients in a VA health care system
    Davis, TM
    Bush, KR
    Kivlahan, DR
    Dobie, DJ
    Bradley, KA
    PSYCHIATRIC SERVICES, 2003, 54 (02) : 214 - 218
  • [43] Taste and appetite disorders of chronic hepatitis C patients
    Musialik, Joanna
    Suchecka, Wanda
    Klimacka-Nawrot, Ewa
    Petelenz, Michal
    Hartman, Magdalena
    Blonska-Fajfrowska, Barbara
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2012, 24 (12) : 1400 - 1405
  • [44] Psychiatric complications of interferon therapy in chronic hepatitis C patients
    Kamijima, K
    Otsubo, T
    Miyaoka, H
    PROGRESS IN HEPATOLOGY, VOL 2: INTERFERON THERAPY ON CHRONIC HEPATITIS C, 1996, 1113 : 67 - 86
  • [45] Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C
    Hilsabeck, RC
    Hassanein, TI
    Carlson, MD
    Ziegler, EA
    Perry, W
    JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2003, 9 (06) : 847 - 854
  • [46] Psychiatric disorders in hepatitis C virus related chronic liver disease.
    Taruschio, G
    Santarini, F
    Sica, G
    Dragoni, C
    Migliorini, S
    Andreone, P
    Cursaro, C
    Gramenzi, A
    Rebecchi, E
    Bernardi, M
    GASTROENTEROLOGY, 1996, 110 (04) : A1342 - A1342
  • [47] Psychiatric and substance use disorders co-morbidities and hepatitis C: Diagnostic and treatment implications
    Peter Hauser
    Shira Kern
    World Journal of Hepatology, 2015, (15) : 1921 - 1935
  • [48] Psychiatric and substance use disorders co-morbidities and hepatitis C: Diagnostic and treatment implications
    Hauser, Peter
    Kern, Shira
    WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (15) : 1921 - 1935
  • [49] Widening the door: The evolution of hepatitis C treatment in patients with psychiatric disorders
    Geppert, Cynthia M. A.
    Arora, Sanjeev
    HEPATOLOGY, 2007, 46 (04) : 957 - 959
  • [50] EFFECTS OF SUBSTANCE-ABUSE ON HALLUCINATION RATES AND TREATMENT RESPONSES IN CHRONIC PSYCHIATRIC-PATIENTS
    SOKOLSKI, KN
    CUMMINGS, JL
    ABRAMS, BI
    DEMET, EM
    KATZ, LS
    COSTA, JF
    JOURNAL OF CLINICAL PSYCHIATRY, 1994, 55 (09) : 380 - 387